Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

O-2050

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Abuse of synthetic cannabinoids (SCs), such as [1-naphthalenyl-(1-pentyl-1H-indol-3-yl]-methanone (JWH-018) and [1-(5… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2012
2012
BACKGROUND AND PURPOSE Rimonabant (SR141716) and the structurally related AM251 are widely used in pharmacological experiments as… Expand
Highly Cited
2011
Highly Cited
2011
Background K2 products are synthetic cannabinoid-laced, marijuana-like drugs of abuse, use of which is often associated with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2011
2011
Rimonabant, the prototypic antagonist of cannabinoid CB(1) receptors, has been reported to have inverse agonist properties at… Expand
Highly Cited
2011
Highly Cited
2011
It is well known that acute challenges with psychostimulants such as amphetamine affect impulsive behavior. We here studied the… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2010
Highly Cited
2010
Background and purpose:  The CB1 cannabinoid receptor and the β2‐adrenoceptor are G protein‐coupled receptors (GPCRs) co… Expand
2010
2010
Endocannabinoids have been shown to activate reward-related feeding and to promote astrocytic differentiation. We investigated… Expand
  • figure 1
  • figure 2
2010
2010
Background and purpose:  Cannabinoid receptor agonists reduce intestinal propulsion in rodents through the CB1 receptor. In… Expand
Highly Cited
2008
Highly Cited
2008
The human mu opioid receptor was expressed stably in Flp-In T-REx HEK293 cells. Occupancy by the agonist DAMGO (Tyr-d-Ala-Gly-N… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2006
Highly Cited
2006
This study compared the effects of the putative cannabinoid receptor 'silent antagonist' O-2050 with the cannabinoid receptor… Expand